Furthermore, it achieved greater improvements in key cardiometabolic risk factors, including glycemic control, body weight, blood pressure, and lipid parameters (Table 3)
This article examines the evidence, risks, and medical guidance to help patients make informed decisions and communicate openly with healthcare professionals about substance use during Wegovy treatment
However, voglibose causes fewer gastrointestinal side effects, such as bloating, than acarbose
doi: 10.3390/healthcare13222958 31 TassoneD
dose adjustment of concomitant medications may be necessary Injection site reactions mild redness, itching, or swelling at the injection site Headache generally mild and self-limiting Rare but serious adverse effects that require immediate medical attention include: Pancreatitis severe, persistent abdominal pain radiating to the back, often accompanied by vomiting Gallbladder problems right upper abdominal pain, particularly after eating fatty meals Diabetic retinopathy complications worsening of existing diabetic eye disease, particularly with rapid glycaemic improvement Acute kidney injury usually secondary to severe dehydration from gastrointestinal effects If you experience any side effects, talk to your doctor, pharmacist or nurse